MarketPeel
EVP R&D, Chief Medical Officer
Wed, Oct 15, 2025
Oct 15
sold $283.78k of ALKS
9,000 shares @ $31.53
Decreased holdings by -10.90%
31st largest trade (out of 157)
Planned (10b5-1)
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 7% above 200-day moving average
ALKSAlkermes plc.
Health CarePharmaceuticals
1D0.00%
1W-1.23%
1M-7.60%
3M+28.30%
6M
1Y

Recent insider activity at ALKS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback